Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 HER-2/neu oncogene amplification and expression in breast and ovarian cancers.

× No keyword cloud information.

12 in total

1. Concomitant oncoprotein detection with fluorescence in situ hybridization (CODFISH): a fluorescence-based assay enabling simultaneous visualization of gene amplification and encoded protein expression.

Authors: R R Tubbs; J Pettay; P Roche; M H Stoler; R Jenkins; J Myles; T Grogan
Journal: J Mol Diagn Date: 2000-05 Impact factor: 5.568

Review 2. Targeting signal transduction for disease therapy.

Authors: A Levitzki
Journal: Med Oncol Date: 1997-06 Impact factor: 3.064

3. Biomarker Development for Brain-Based Disorders: Recent Progress in Psychiatry.

Authors: James O Ebot Enaw; Alicia K Smith
Journal: J Neurol Psychol Date: 2013-11-01

4. Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assay.

Authors: J P Vaughn; J D Iglehart; S Demirdji; P Davis; L E Babiss; M H Caruthers; J R Marks
Journal: Proc Natl Acad Sci U S A Date: 1995-08-29 Impact factor: 11.205

5. Heregulins and the ErbB-2/3/4 receptors in gliomas.

Authors: M Westphal; L Meima; E Szonyi; J Lofgren; H Meissner; W Hamel; K Nikolics; M X Sliwkowski
Journal: J Neurooncol Date: 1997-12 Impact factor: 4.130

6. Inhibition of the erbB-2 tyrosine kinase receptor in breast cancer cells by phosphoromonothioate and phosphorodithioate antisense oligonucleotides.

Authors: J P Vaughn; J Stekler; S Demirdji; J K Mills; M H Caruthers; J D Iglehart; J R Marks
Journal: Nucleic Acids Res Date: 1996-11-15 Impact factor: 16.971

HER-2/neu oncogene amplification and expression in breast and ovarian cancers.

1. Concomitant oncoprotein detection with fluorescence in situ hybridization (CODFISH): a fluorescence-based assay enabling simultaneous visualization of gene amplification and encoded protein expression.

Review 2. Targeting signal transduction for disease therapy.

3. Biomarker Development for Brain-Based Disorders: Recent Progress in Psychiatry.

4. Antisense DNA downregulation of the ERBB2 oncogene measured by a flow cytometric assay.

5. Heregulins and the ErbB-2/3/4 receptors in gliomas.

6. Inhibition of the erbB-2 tyrosine kinase receptor in breast cancer cells by phosphoromonothioate and phosphorodithioate antisense oligonucleotides.

7. Migration of fresh human malignant astrocytoma cells into hydrated gel wafers in vitro.

8. Maintenance of DNA content and erbB-2 alterations in intraductal and invasive phases of mammary cancer.

Review 9. The role of trastuzumab in early stage breast cancer: current data and treatment recommendations.

10. Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer.